AstraZeneca, Sanofi Jump On First-Quarter Earnings; Bristol Myers LagsInvestors Business Daily • 04/25/24
Press Release: Sanofi Q1: robust 7% sales growth driven by launches, underpins full-year guidanceGlobeNewsWire • 04/25/24
FTC looking to accelerate inquiry into prescription-drug middlemen, chair saysMarket Watch • 04/23/24
Press Release: Rilzabrutinib LUNA 3 phase 3 study met primary endpoint in immune thrombocytopeniaGlobeNewsWire • 04/23/24
COTA Announces Strategic Collaboration with Sanofi to Leverage Real-World Data and AI to Accelerate Cancer TrialsBusiness Wire • 04/17/24
Press Release: New 48-week frexalimab phase 2 data support potential for high sustained efficacy in multiple sclerosisGlobeNewsWire • 04/17/24
Big pharma is looking to fatten profits with buyouts of weight-loss drug companies. Here are 4 candidates.Market Watch • 04/16/24
Meet Europe's Mag 18. Novo Nordisk Stock, ASML, and Others Can Rival the Mag Seven.Barrons • 04/09/24
Sanofi Announces Launch of Verorab® (Sanofi Inactivated Rabies Vaccine) in the UK for Pre-exposure and Post-exposure Prophylaxis of Rabies in All Age GroupsBusiness Wire • 04/05/24
Diabetes drug similar to Ozempic helped slow progression of Parkinson's disease in small trialCNBC • 04/04/24
Diabetes medication appears to slow progress of Parkinson's disease in French-backed trialMarket Watch • 04/04/24
Kymera Therapeutics: Advancing Into Phase 2 With Partner Sanofi - I Still Have FaithSeeking Alpha • 03/21/24
